Cardiovascular Market Research Reports & Industry Analysis

Caused by heart and/or blood-vascular system disorders, cardiovascular (CDV) diseases kill almost 17 million people annually. The cardiovascular market can be divided the following key segments: cardiac surgery, cardiac rhythm management (abbreviated as CRM) and interventional cardiology. There is a wide range of products on offer in the market: defibrillators, introducers, catheters, pacemakers, among others.

The growth of the cardiovascular market is driven by the aging population, rising incidence of chronic CDV, innovations and technology advancements in the cardiovascular industry and constantly improving treatment capabilities. The USA is the largest cardiovascular market, with AstraZeneca , Merck & Co. , Bristol-Myers Squibb (BMS), Novartis , Sanofi-Aventis and Pfizerbeing amid the most prominent market participants.

Comprehensive assessment of the cardiovascular market at various geographical scales and over different time spans is provided in the research reports found under this catalogue. Data demand and supply trends, research and development activities, and leading market players are at hand in the reports. Moreover, future prospects for the market are disclosed in the research reports.

Found 350 publications
Cardiovascular Deals and Alliances of 2013 US$ 1,495.00

The Cardiovascular Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered ... signed by bigpharma and bigbiotech, and most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online ...

Mar, 2014 200 pages
Sectoral Capsule-The Heart of the Matter-Cardiovascular Market in India US$ 250.00

The capsule reports are concise information about the industry; and the opportunities & challenges that it carries. It gives the past as well as ... of the industry with all relevant inputs in place. The dynamics that propel the sector, namely, opportunities, competition, infrastructure investment and regulatory ...

Jan, 2014 16 pages
Ventricular Tachycardia Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... and data relating to the clinical trials on Ventricular Tachycardia. It includes an overview of the trial numbers and their recruitment status as per the ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Dec, 2013 74 pages
Ventricular Fibrillation Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... and data relating to the clinical trials on Ventricular Fibrillation. It includes an overview of the trial numbers and their recruitment status as per the ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Dec, 2013 60 pages
Venous Thromboembolism Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... and data relating to the clinical trials on Venous Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Dec, 2013 125 pages
Thromboembolism Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... Summary GlobalData's clinical trial report, 'Thromboembolism Global Clinical Trials Review, H2, 2013' provides data on the Thromboembolism clinical trial scenario. This ... and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / ...

Dec, 2013 175 pages
Regurgitation Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... 2013 Summary GlobalData's clinical trial report, 'Regurgitation Global Clinical Trials Review, H2, 2013' provides data on the Regurgitation clinical trial scenario. This ... and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities ...

Dec, 2013 87 pages
Mitral Regurgitation Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... and data relating to the clinical trials on Mitral Regurgitation. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Dec, 2013 63 pages
Hypoxemia Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... 2013 Summary GlobalData's clinical trial report, 'Hypoxemia Global Clinical Trials Review, H2, 2013' provides data on the Hypoxemia clinical trial scenario. This ... type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / ...

Dec, 2013 63 pages
Chronic Stable Angina Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... Review, H2, 2013' provides data on the Chronic Stable Angina clinical trial scenario. This report provides elemental information and data relating ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Dec, 2013 69 pages
Bradycardia Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... 2013 Summary GlobalData's clinical trial report, 'Bradycardia Global Clinical Trials Review, H2, 2013' provides data on the Bradycardia clinical trial scenario. This ... type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities ...

Dec, 2013 62 pages
Atrial Flutter Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... and data relating to the clinical trials on Atrial Flutter. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Dec, 2013 120 pages
Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use US$ 3,500.00

... GBI Research has released its pharmaceutical research, "Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue ... restraints that have had and are expected to have a significant impact upon the market Key licensing and co-development agreements in the ...

Nov, 2013 93 pages
Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat US$ 3,500.00

... Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat Summary GBI Research has released its pharmaceutical research, "Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat", which provides ...

Nov, 2013 106 pages
Vascular Dysfunction - Pipeline Review, H2 2013 US$ 2,000.00

... , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vascular Dysfunction. Vascular Dysfunction - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s ...

Nov, 2013 35 pages
MediPoint: Peripheral Vascular Stents - Global Analysis and Market Forecasts US$ 6,495.00

MediPoint: Peripheral Vascular Stents - Global Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat ... and infrapopliteal arteries in the lower extremity? Bare metal and covered stents have been on the market for many years; however, unmet needs ...

Apr, 2013 402 pages
Physician Views: How have cardiologists, internal medicine specialists and general practitioners reacted to the new AHA/ACC cholesterol management guidelines US$ 645.00

... . Discussing the commercial opportunity for the PCSK9 inhibitors, a number of analysts have pointed out, however, that initial uptake of these new products will ... with the PCSK9 inhibitors. This week’s Physician Views poll will ask US-based cardiologists, general practioners and internal medicine specialists a ...

Nov, 2013
India Interventional Cardiology Market Trends Until 2018 US$ 2,000.00

... This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in India through 2018. The product ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

Apr, 2012 18 pages
France Interventional Cardiology Market Trends Until 2018 US$ 2,000.00

... This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in France through 2018. The product ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

Apr, 2012 18 pages
China Interventional Cardiology Market Trends Until 2018 US$ 2,000.00

... This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in China through 2018. The product ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

Apr, 2012 18 pages
Canada Interventional Cardiology Market Trends Until 2018 US$ 2,000.00

... This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in Canada through 2018. The product ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

Apr, 2012 18 pages
Canada Cardiovascular Surgery Market Trends Until 2018 US$ 2,000.00

... This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular surgery in Canada through 2018. The product ... comparison for product categories, historic and forecast through 2018. Market share of companies. Average selling price ($) for each product type ( ...

Apr, 2012 18 pages
Australia Interventional Cardiology Market Trends Until 2018 US$ 2,000.00

... research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in Australia through 2018. The product ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

Apr, 2012 18 pages
UK Market for Peripheral Vascular Devices Through 2018 US$ 2,100.00

... Description This research report provides key market trends, market forecasts and competitive scenario of the peripheral vascular devices (PVD) in the UK through ... Scope The report highlights historic and forecasted Market size in terms of revenues & unit sales, average selling price, growth rates, and ...

Oct, 2013 31 pages
UK Market for Interventional Cardiology Through 2018 US$ 2,100.00

... This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in the UK through 2018. The ... (ACDs) Scope The report highlights historic and forecasted Market size in terms of revenues & unit sales, average selling price, growth rates, and ...

Oct, 2013 48 pages
Spain Heart Valve and Repair Market Outlook and Trends Till 2018 US$ 2,100.00

... key market trends, market forecasts and competitive scenario of the cardiovascular heart valve and repair in Spain through 2018. The product categories covered in this report include: Heart Valve Annuloplasty Rings Scope The report highlights historic and forecasted Market size ...

Oct, 2013 23 pages
North America Cardiovascular Devices Market Assessment and Forecasts To 2018 US$ 4,200.00

... Intelligence report provides critical market data for cardiovascular devices and its product categories for the North American region and ... and 2012 to 2018. Recent events and developments Cardiovascular Devices Market Segmentation Cardiac Assist Devices Total Artificial Heart Ventricular Assist ...

Oct, 2013 186 pages
Japan Market for Peripheral Vascular Devices Through 2018 US$ 2,100.00

... research report provides key market trends, market forecasts and competitive scenario of the peripheral vascular devices (PVD) in Japan through 2018. The ... PTA Balloon Grafts Scope The report highlights historic and forecasted Market size in terms of revenues & unit sales, average selling price, growth ...

Oct, 2013 31 pages
Japan Market for Interventional Cardiology Through 2018 US$ 2,100.00

... This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in Japan through 2018. The product ... comparison for product categories, historic and forecast through 2018. Market share of companies. Average selling price ($) for each product type ...

Oct, 2013 48 pages
Heart Attack - Pipeline Review, H2 2013 US$ 2,000.00

... and discontinued projects. It also reviews key players involved in the therapeutic development for Heart Attack. Heart Attack - Pipeline Review, Half Year is ... news and deals relating to the products. Reasons to buy Identify and understand important and diverse types of therapeutics under development for ...

Oct, 2013 37 pages
Cardiac Fibrosis - Pipeline Review, H2 2013 US$ 2,000.00

... discontinued projects. It also reviews key players involved in the therapeutic development for Cardiac Fibrosis. Cardiac Fibrosis - Pipeline Review, Half Year ... news and deals relating to the products. Reasons to buy Identify and understand important and diverse types of therapeutics under development for ...

Oct, 2013 43 pages
Physician Views: How do European cardiologists perceive oral anticoagulants versus warfarin? – Is Eliquis, Pradaxa or Xarelto their favoured option? US$ 645.00

... is expected to double over the next 12 months. This week's FirstWord Physician Views poll will ask: How do the clinical profiles of oral anticoagulants compare with warfarin? How does the clinical profile of Eliquis compare to other oral anticoagulants? Which product – Eliquis, ...

Sep, 2013
The Top 25 Manufacturers Of Point-Of-Care Diagnostics For Cardiovascular Medicine US$ 234.00

... Products, Technology, Disease Areas, Parent Company, Year Established, Number of Employees and Turnover. Report Target Market: 1) Point-Of-Care Manufacturing Companies Usage: competitive/financial analysis and strategic partner/alliance identification. 2) Point-Of-Care Suppliers This report is perfect ...

Jun, 2012 60 pages
The Top 50 Contract Research Organisations In Western Europe For Cardiovascular Diseases & Disorders US$ 732.00

... , Stroke, Thrombosis etc. They are located right across Western Europe from the United Kingdom and Ireland to Germany and France. ... , Biotechnology and Medical Device Associations The Top 50 Contract Research Organisations In Western Europe For Cardiovascular Diseases & Disorders is a useful reference tool ...

Aug, 2013 144 pages
Nuclear Cardiology Markets US$ 3,400.00

... in procedural volumes. This TriMark Publications study discusses key products in nuclear cardiology and examines the trends that are stimulating this ... in depth. The primarily focus on three major segments of the nuclear cardiology market: 1) devices, 2) PACS (picture archiving and communications systems) and ...

May, 2011 252 pages
Cardiac Rhythm Management Devices World Markets US$ 3,400.00

... (VF). These cardiac disorders are treated with the aid of different types of electronic cardiac devices. This TriMark Publications report focuses on the global and regional markets for all cardiac rhythm management (CRM) devices, and includes data on implant volumes, procedure costs and ...

Oct, 2011 250 pages
Cardiac Marker Diagnostic Testing Markets US$ 3,400.00

Cardiac marker diagnostic testing measures the concentration of certain proteins, i.e., biomarkers, which indicate the presence or severity of cardiovascular disease (CVD). Among the most prevalent CVDs are sudden cardiac arrest (SCA), acute myocardial infarction (AMI), congestive heart failure (CHF) and ...

Nov, 2011 139 pages
Cardiometabolic Disease - Pipeline Review, H2 2013 US$ 2,000.00

... Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiometabolic Disease. Cardiometabolic Disease - Pipeline Review, Half Year is built using data and information sourced ...

Jul, 2013 31 pages
Ischemic Cerebral Stroke - Pipeline Review, H1 2013 US$ 2,000.00

... Cerebral Stroke, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ... on the basis of monotherapy and combined therapeutics. Coverage of the Ischemic Cerebral Stroke pipeline on the basis of route of administration and molecule type ...

Jun, 2013 24 pages
The World Market for Cardiovascular Diagnostics US$ 3,995.00

... markers Cardiac contrast agents and radiopharmaceuticals For each of these segments, market size and forecast, along with compound annual growth rate is ... within the global cardiac diagnostics market remained challenging in 2012. Demand for cardiovascular diagnostics slowed during the historical period due ...

Jun, 2013 180 pages
Cardiovascular Disease – Pipeline Review, H1 2013 US$ 2,000.00

... Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cardiovascular Disease. Cardiovascular Disease - Pipeline Review, Half Year is built using data and information sourced ...

Jun, 2013 553 pages
Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons’ Confidence and Proficiency to Drive TAVR Procedure Volumes US$ 3,500.00

... to Drive TAVR Procedure Volumes Summary GBI Research’s “Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing ... trends affecting these segments, and key analytical content related to market dynamics. The report also reviews the competitive landscape and ...

Jun, 2013 111 pages
Ischemic Cardiomyopathy – Pipeline Review, H1 2013 US$ 2,000.00

... , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ischemic Cardiomyopathy. Ischemic Cardiomyopathy - Pipeline Review, Half Year is built using data and information sourced from ...

May, 2013 37 pages
Cardiovascular Risk Factors – Pipeline Review, H1 2013 US$ 2,000.00

... Risk Factors, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ... on the basis of monotherapy and combined therapeutics. Coverage of the Cardiovascular Risk Factors pipeline on the basis of route of administration and molecule type ...

May, 2013 465 pages
Acute Inflammation – Pipeline Review, H1 2013 US$ 2,000.00

... key players involved in the therapeutic development for Acute Inflammation. Acute Inflammation - Pipeline Review, Half Year is built using data and ... on the basis of route of administration and molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products. Identify and ...

May, 2013 33 pages
MediPoint: Peripheral Vascular Stents for the Lower Extremity - US Analysis and Market Forecasts US$ 4,450.00

MediPoint: Peripheral Vascular Stents for the Lower Extremity - US Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been ... India. Through GlobalData’s analysis, it is evident that currently the peripheral vascular stent market for the lower extremity is saturated with bare ...

Apr, 2013 331 pages
MediPoint: Peripheral Vascular Stents for the Lower Extremity - South America Analysis and Market Forecasts US$ 4,450.00

MediPoint: Peripheral Vascular Stents for the Lower Extremity - South America Analysis and Market Forecasts Summary Endovascular therapies such as stenting ... for the lower extremity is saturated with bare metal stents, followed by covered stents. However, as clinical data and appropriate reimbursement and ...

Apr, 2013 313 pages
MediPoint: Peripheral Vascular Stents for the Lower Extremity - EU Analysis and Market Forecasts US$ 4,450.00

MediPoint: Peripheral Vascular Stents for the Lower Extremity - EU Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been ... India. Through GlobalData’s analysis, it is evident that currently the peripheral vascular stent market for the lower extremity is saturated with bare ...

Apr, 2013 370 pages
MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players US$ 3,500.00

... Summary GlobalData has released its medical devices report, “MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future ... high level view of the trends shaping and driving the Peripheral Vascular Stent (PVS) market. Assess competitiveness of products in market by understanding the ...

Apr, 2013 247 pages
MediPoint: Peripheral Vascular Stents for the Lower Extremity - APAC Analysis and Market Forecasts US$ 4,450.00

MediPoint: Peripheral Vascular Stents for the Lower Extremity - APAC Analysis and Market Forecasts Summary Endovascular therapies such as stenting have ... including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon angioplasty alone ...

Apr, 2013 359 pages
1 2 3 4 5 >
Skip to top